Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 46


Impaired Angiogenic Potential of Human Placental Mesenchymal Stromal Cells in Intrauterine Growth Restriction.

Mandò C, Razini P, Novielli C, Anelli GM, Belicchi M, Erratico S, Banfi S, Meregalli M, Tavelli A, Baccarin M, Rolfo A, Motta S, Torrente Y, Cetin I.

Stem Cells Transl Med. 2016 Apr;5(4):451-63. doi: 10.5966/sctm.2015-0155. Epub 2016 Mar 8.


Stem Cell-Mediated Exon Skipping of the Dystrophin Gene by the Bystander Effect.

Meregalli M, Farini A, Sitzia C, Beley C, Razini P, Cassinelli L, Colleoni F, Frattini P, Santo N, Galbiati E, Prosperi D, Tavelli A, Belicchi M, Garcia L, Torrente Y.

Curr Gene Ther. 2015;15(6):563-71.


Improvement of endurance of DMD animal model using natural polyphenols.

Sitzia C, Farini A, Colleoni F, Fortunato F, Razini P, Erratico S, Tavelli A, Fabrizi F, Belicchi M, Meregalli M, Comi G, Torrente Y.

Biomed Res Int. 2015;2015:680615. doi: 10.1155/2015/680615. Epub 2015 Mar 15.


P(NIPAAM-co-HEMA) thermoresponsive hydrogels: an alternative approach for muscle cell sheet engineering.

Villa C, Martello F, Erratico S, Tocchio A, Belicchi M, Lenardi C, Torrente Y.

J Tissue Eng Regen Med. 2014 May 5. doi: 10.1002/term.1898. [Epub ahead of print]


Stem cell salvage of injured peripheral nerve.

Grimoldi N, Colleoni F, Tiberio F, Vetrano IG, Cappellari A, Costa A, Belicchi M, Razini P, Giordano R, Spagnoli D, Pluderi M, Gatti S, Morbin M, Gaini SM, Rebulla P, Bresolin N, Torrente Y.

Cell Transplant. 2015;24(2):213-22. doi: 10.3727/096368913X675700. Epub 2013 Nov 21.


Full-length dysferlin expression driven by engineered human dystrophic blood derived CD133+ stem cells.

Meregalli M, Navarro C, Sitzia C, Farini A, Montani E, Wein N, Razini P, Beley C, Cassinelli L, Parolini D, Belicchi M, Parazzoli D, Garcia L, Torrente Y.

FEBS J. 2013 Dec;280(23):6045-60. doi: 10.1111/febs.12523. Epub 2013 Oct 8.


Polyglycolic acid-polylactic acid scaffold response to different progenitor cell in vitro cultures: a demonstrative and comparative X-ray synchrotron radiation phase-contrast microtomography study.

Giuliani A, Moroncini F, Mazzoni S, Belicchi ML, Villa C, Erratico S, Colombo E, Calcaterra F, Brambilla L, Torrente Y, Albertini G, Della Bella S.

Tissue Eng Part C Methods. 2014 Apr;20(4):308-16. doi: 10.1089/ten.TEC.2013.0213. Epub 2013 Sep 5.


Micro-CT technique for three-dimensional visualization of human stem cells.

Farini A, Villa C, Belicchi M, Meregalli M, Torrente Y.

Methods Mol Biol. 2013;1052:143-52. doi: 10.1007/7651_2013_23.


Perspectives of stem cell therapy in Duchenne muscular dystrophy.

Meregalli M, Farini A, Belicchi M, Parolini D, Cassinelli L, Razini P, Sitzia C, Torrente Y.

FEBS J. 2013 Sep;280(17):4251-62. doi: 10.1111/febs.12083. Epub 2013 Jan 7. Review.


CD133(+) Cells for the Treatment of Degenerative Diseases: Update and Perspectives.

Meregalli M, Farini A, Belicchi M, Torrente Y.

Adv Exp Med Biol. 2013;777:229-43. doi: 10.1007/978-1-4614-5894-4_15.


Expression of CD20 reveals a new store-operated calcium entry modulator in skeletal muscle.

Parolini D, Cassinelli L, Razini P, Sitzia C, Tonna N, Erratico S, Colleoni F, Angeloni V, Maffioli E, Farini A, Maciotta S, Porretti L, Belicchi M, Bianco F, Tedeschi G, Meregalli M, Torrente Y.

Int J Biochem Cell Biol. 2012 Dec;44(12):2095-105. doi: 10.1016/j.biocel.2012.09.001. Epub 2012 Sep 12.


Novel insight into stem cell trafficking in dystrophic muscles.

Farini A, Villa C, Manescu A, Fiori F, Giuliani A, Razini P, Sitzia C, Del Fraro G, Belicchi M, Meregalli M, Rustichelli F, Torrente Y.

Int J Nanomedicine. 2012;7:3059-67. doi: 10.2147/IJN.S30595. Epub 2012 Jun 20.


Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model.

Farini A, Sitzia C, Navarro C, D'Antona G, Belicchi M, Parolini D, Del Fraro G, Razini P, Bottinelli R, Meregalli M, Torrente Y.

Exp Cell Res. 2012 Jun 10;318(10):1160-74. doi: 10.1016/j.yexcr.2012.03.010. Epub 2012 Mar 23.


CD133(+) cells isolated from various sources and their role in future clinical perspectives.

Meregalli M, Farini A, Belicchi M, Torrente Y.

Expert Opin Biol Ther. 2010 Nov;10(11):1521-8. doi: 10.1517/14712598.2010.528386. Epub 2010 Oct 11. Review.


In vivo tracking of stem cell by nanotechnologies: future prospects for mouse to human translation.

Villa C, Erratico S, Razini P, Farini A, Meregalli M, Belicchi M, Torrente Y.

Tissue Eng Part B Rev. 2011 Feb;17(1):1-11. doi: 10.1089/ten.TEB.2010.0362. Epub 2010 Oct 29. Review.


Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy.

Lerario A, Cogiamanian F, Marchesi C, Belicchi M, Bresolin N, Porretti L, Torrente Y.

BMC Musculoskelet Disord. 2010 Jul 11;11:157. doi: 10.1186/1471-2474-11-157.


Stem cell tracking by nanotechnologies.

Villa C, Erratico S, Razini P, Fiori F, Rustichelli F, Torrente Y, Belicchi M.

Int J Mol Sci. 2010 Mar 12;11(3):1070-81. doi: 10.3390/ijms11031070. Review.


Ex vivo expansion of human circulating myogenic progenitors on cluster-assembled nanostructured TiO2.

Belicchi M, Erratico S, Razini P, Meregalli M, Cattaneo A, Jacchetti E, Farini A, Villa C, Bresolin N, Porretti L, Lenardi C, Milani P, Torrente Y.

Biomaterials. 2010 Jul;31(20):5385-96. doi: 10.1016/j.biomaterials.2010.03.021. Epub 2010 Apr 15.


Expression of parathyroid-specific genes in vascular endothelial progenitors of normal and tumoral parathyroid glands.

Corbetta S, Belicchi M, Pisati F, Meregalli M, Eller-Vainicher C, Vicentini L, Beck-Peccoz P, Spada A, Torrente Y.

Am J Pathol. 2009 Sep;175(3):1200-7. doi: 10.2353/ajpath.2009.080979. Epub 2009 Jul 30.


In vivo myogenic potential of human CD133+ muscle-derived stem cells: a quantitative study.

Negroni E, Riederer I, Chaouch S, Belicchi M, Razini P, Di Santo J, Torrente Y, Butler-Browne GS, Mouly V.

Mol Ther. 2009 Oct;17(10):1771-8. doi: 10.1038/mt.2009.167. Epub 2009 Jul 21.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk